Quanterix Corporation
General ticker "QTRX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $246.7M (TTM average)
Quanterix Corporation does not follow the US Stock Market performance with the rate: -15.1%.
Estimated limits based on current volatility of 1.5%: low 2.48$, high 2.61$
Factors to consider:
- Total employees count: 450 (-4.5%) as of 2025
- North America accounted for 2.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Economic downturns and volatility, Stock value fluctuation, Market acceptance, Product defects, Regulatory and compliance
- Current price 35.8% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.07$, 9.57$]
- 2026-12-31 to 2027-12-31 estimated range: [4.13$, 9.59$]
Financial Metrics affecting the QTRX estimates:
- Negative: with PPE of -2.7 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -27.82 <= 0.28
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of 18.10 > -0.64
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -3.46 <= 0
Short-term QTRX quotes
Long-term QTRX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $122.37MM | $137.42MM | $138.90MM |
| Operating Expenses | $172.07MM | $190.04MM | $264.44MM |
| Operating Income | $-49.70MM | $-52.62MM | $-125.54MM |
| Non-Operating Income | $18.09MM | $14.52MM | $13.27MM |
| R&D Expense | $24.86MM | $31.08MM | $35.92MM |
| Income(Loss) | $-31.61MM | $-38.10MM | $-112.27MM |
| Taxes | $0.72MM | $0.43MM | $-5.12MM |
| Net Income(Loss)* | $-32.33MM | $-38.53MM | $-107.15MM |
| Stockholders Equity | $346.93MM | $330.04MM | $295.73MM |
| Inventory | $26.12MM | $32.77MM | $54.76MM |
| Assets | $425.01MM | $406.53MM | $418.77MM |
| Operating Cash Flow | $-18.90MM | $-35.16MM | $-77.24MM |
| Capital expenditure | $3.79MM | $3.37MM | $2.61MM |
| Investing Cash Flow | $-148.40MM | $-82.27MM | $50.23MM |
| Financing Cash Flow | $2.69MM | $0.46MM | $-0.71MM |
| Earnings Per Share** | $-0.86 | $-1.00 | $-2.51 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.